drugset / Trial / NCT00255996

Evaluation Of Linezolid Pk Profile In Burns Patients

NCT00255996

Phase 1 Completed 16 enrolled Pfizer
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of linezolid pk profile in burns patients

Timeline

Start
2006-05
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Linezolid Other / unclassified Intravenous

Indications

No indication recorded.